NCT01806376View on ClinicalTrials.gov

A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics

PHASE1UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Solid Tumor
Interventions
DRUG

Subutinib Maleate capsules

Dose escalation will be dependent on any dose limiting toxicities

Trial Locations (1)

200032

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

Sponsors
All Listed Sponsors
collaborator

Fudan University

OTHER

lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY